Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Tobacco Use Cessation: later-stage trial registry
12 of 37 indexed Tobacco Use Cessation trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #406 of 28,707 conditions by registered trial count.
37 US clinical trials · 12 currently recruiting · #406 of 28,707 conditions by registered trial count
Tobacco Use Cessation: 37 US clinical trials tracked, 12 recruiting.
Tobacco Use Cessation is the subject of 37 registered US clinical trials on ClinicalTrials.gov, 12 of them currently open to new participants. 7 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Washington University School of Medicine, running 3 of these trials.
Enrollment posture brief
Registry condition tobacco-use-cessation
OPEN 12 | RECR 32% | LATE 7 | EARLY 4 | RANK #406 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Graft Vs Host Disease (32% recruiting · 37 trials)
Tobacco Use Cessation lists 12 open slots (32% of 37 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Tobacco Use Cessation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Tobacco Use Cessation is recruiting below its size-band peers.
12 of 37 indexed trials (32.4%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Tobacco Use Cessation trials is spread across many organizations.
Washington University School of Medicine accounts for 3 of 37 trials (8.1%). 29 distinct sponsors appear on at least one study for this condition label.
-
Typical Tobacco Use Cessation enrolment sits around 204 participants.
Median target enrolment is 204 among the 37 trials that report a genuine target (sentinel values excluded). 8 of those (21.6%) plan for fewer than 100 participants.
-
Tobacco Use Cessation research is mostly interventional.
36 interventional and 1 observational studies make up this index (97.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
37 total, page 1 of 1
CONNECT Cancer Survivors With Tobacco Treatment
Washington University School of Medicine
NCT07020273
Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)
University of Illinois at Chicago
NCT04827420
Reach Through Equitable Implementation in Utah
University of Utah
NCT06881069
Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care
University of Florida
NCT05415761
Smoking Cessation Program in the Construction Sector
University of Miami
NCT06098144
Cannabis-Tobacco Co-Use Treatment Study
Medical University of South Carolina
NCT06883162
Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness
University of California, San Francisco
NCT07148232
Development of a Smoking Cessation Video Series
Wayne State University
NCT06443294
Integrating CHWs Into Prenatal Care for Maternal Smoking Cessation
Loma Linda University
NCT06438549
Comprehensive Tobacco Cessation for Cancer Patients and Survivors
Virginia Commonwealth University
NCT05805722
Oral Cannabidiol for Tobacco Cessation
Johns Hopkins University
NCT05445804
Trauma-Informed Care for Smoking Cessation for Pregnancy
University of California, San Francisco
NCT07129590
Ask Advise Connect (AAC) Harris Heath CPRIT
M.D. Anderson Cancer Center
NCT01788787
Cessation Clinical Trial
Truth Initiative
NCT06806098
A Pragmatic Trial of Chronic Disease Approaches to Ameliorate Tobacco Related Cardiovascular Disease Health Disparities
University of Minnesota
NCT05671380
Development of UP2UTobacco for High School Youth
University of Virginia
NCT05396911
Reward Sensitivity and Pharmacotherapy for Smoking Cessation
M.D. Anderson Cancer Center
NCT02162849
Feasibility of Delivering VergeRx at FQHCs
University of Virginia
NCT06161675
Tobacco Quitlines:Adjunct to Dental Office Tobacco Intervention
Oregon Research Institute
NCT00384254
Interventions to Help More Low-income Smokers Quit
Washington University School of Medicine
NCT04311983
Helping Poor Smokers Quit
Washington University School of Medicine
NCT03194958
Quit and Win Contests to Improve Smoking Cessation Among College Students
University of Minnesota
NCT01096108
Disseminating an Evidence-based Tobacco Control Intervention for School Teachers in India
Glorian Sorensen
NCT05346991
Telephone Counseling for Snuff Users
HealthPartners Institute
NCT00265681
A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV
Yale University
NCT04490057
Quit and Fit: Teen Smoking Cessation
West Virginia University
NCT01242657
Tobacco Tactics Website for Operating Engineers
University of Michigan
NCT01124110
Tobacco Cessation Via Doctors of Chiropractic
Oregon Research Institute
NCT00386945
Effectiveness of Bupropion for Treating Nicotine Dependence in Young People
National Institute on Drug Abuse (NIDA)
NCT00129272
A Facebook Intervention for Young Sexual and Gender Minority Smokers
University of California, San Francisco
NCT03259360
Improving Adherence to Smoking Cessation Medication Among PLWHA
NYU Langone Health
NCT01898195
Evaluating a Web-Based Cardiovascular Disease Risk Factor Reduction Program Among American Indians
Black Hills Center for American Indian Health
NCT00608387
Connecting Alaska Native People to Quit Smoking
Mayo Clinic
NCT03645941
Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts
Brown University
NCT04994444
Engagement With an Adaptive Mobile Health Smoking Cessation Intervention
Massachusetts General Hospital
NCT04020718
Feasibility of a Culturally-Specific Video Text Cessation Intervention With AA Quitline Callers
Case Comprehensive Cancer Center
NCT03927976
Pilot Trial of Using SmokeBeat to Monitor and Increase Smoking Abstinence in Pregnant Women
University of Pennsylvania
NCT03209557
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 2 |
| Phase 4 | 5 |
Top Sponsors
Named interventions
Most-linked intervention names on Tobacco Use Cessation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Tobacco Use Cessation trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Tobacco Use Cessation page
37 registered trials, 12 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 12 Tobacco Use Cessation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Washington University School of Medicine sponsors the most Tobacco Use Cessation trials on record, review their full trial history before evaluating a specific study. See Washington University School of Medicine's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Tobacco Use Cessation condition card totals 37 registered trials; most-linked intervention Varenicline; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.